WanburyWANBURY 
-4.30%24h
Wanbury (WANBURY) Stock Overview
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
WANBURY Stock Information
Wanbury (WANBURY) Price Chart
Wanbury Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $2.74 | N/A |
| Market Cap | $89.64M | N/A |
| Shares Outstanding | 32.69M | 1.48% |
| Employees | 1.58K | N/A |
| Shareholder Equity | -328.16M | 40.12% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | -0.86 | N/A |
| P/S Ratio | 1.51 | N/A |
| P/B Ratio | -0.27 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | 0.0038 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $59.31M | N/A |
| Earnings | -$1.24M | N/A |
| EPS | -3.18 | N/A |
| Earnings Yield | -1.16 | N/A |
| Gross Margin | 0.3814 | N/A |
| Operating Margin | 0.0238 | N/A |
| Net income margin | -0.0209 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $36.18M | N/A |
| Total Debt | $12.93M | N/A |
| Cash on Hand | $572.02K | N/A |
| Debt to Equity | -0.1222 | -36.09% |
| Cash to Debt | 0.0442 | -78.97% |
| Current Ratio | 0.3875 | -19.52% |
